# A Rare Coexistence of Smoldering Multiple Myeloma and JAK2-Positive Myeloproliferative Neoplasm: A Case of Dual Synchronous Hematological Malignancy

**Authors:** Adnane Hammani, Othman Doghmi, Mohammed Allaoui, Mounir Ababou, El Mehdi Mahtat, Hicham El Maaroufi, Kamal Doghmi

PMC · DOI: 10.7759/cureus.52622 · Cureus · 2024-01-20

## TL;DR

An 82-year-old man had two rare blood cancers at the same time, prompting research into their possible connection and treatment challenges.

## Contribution

This case highlights the rare coexistence of JAK2-positive MPN and SMM, suggesting a need for further investigation into their potential interplay.

## Key findings

- The patient had essential thrombocythemia and smoldering multiple myeloma diagnosed simultaneously.
- The coexistence of these two distinct hematological malignancies is extremely rare and poorly understood.
- The case emphasizes the need for individualized treatment approaches due to the complex risks involved.

## Abstract

This article explores the rare case of an 82-year-old man diagnosed concurrently with essential thrombocythemia and smoldering multiple myeloma (SMM). The limited existing literature on individuals harboring both myeloproliferative neoplasm (MPN) and monoclonal gammopathy (MG) is of significant interest due to the distinct origins of these malignancies. The etiology of MG in MPN patients remains elusive, leading to speculation about a potential relationship or interplay between the two conditions. This unique case prompts a deeper exploration of the mechanisms underlying the coexistence of JAK2-positive MPN and SMM. It underscores the importance of tailored therapeutic strategies that carefully consider the inherent risks and potential adverse outcomes associated with these specific malignancies, thereby warranting further clinical research.

## Linked entities

- **Diseases:** essential thrombocythemia (MONDO:0005029), smoldering multiple myeloma (MONDO:0005235), myeloproliferative neoplasm (MONDO:0020076), monoclonal gammopathy (MONDO:0004960)

## Full-text entities

- **Genes:** JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}
- **Diseases:** MPN (MESH:D009369), Hematological Malignancy (MESH:D019337), Multiple Myeloma (MESH:D009101), SMM (MESH:D000075122), essential thrombocythemia (MESH:D013920), MG (MESH:D010265)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10876019/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10876019/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC10876019/full.md

---
Source: https://tomesphere.com/paper/PMC10876019